| Date Filed | Type | Description |
| 10/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/24/2020 |
4
| Jenne Kyle (Chief Commercial Officer) has filed a Form 4 on AKCEA THERAPEUTICS, INC.|
Txns:
| Sold 720 shares
@ $18.12, valued at
$13k
|
|
| 09/24/2020 |
4
| McDevitt Damien (CEO) has filed a Form 4 on AKCEA THERAPEUTICS, INC.|
Txns:
| Sold 8,709 shares
@ $18.12, valued at
$157.8k
|
|
| 09/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/20/2020 |
4
| Patterson Joshua F. (General Counsel) has filed a Form 4 on AKCEA THERAPEUTICS, INC.|
Txns:
| Sold 263 shares
@ $12.5011, valued at
$3.3k
|
|
| 07/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/10/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/19/2020 |
4
| PRICE MICHAEL DENNIS (CFO) has filed a Form 4 on AKCEA THERAPEUTICS, INC.|
Txns:
| Granted 50,000 shares
@ $0
Granted 300,000 options to buy
@ $14.78, valued at
$4.4M
|
|
| 05/19/2020 |
3
| PRICE MICHAEL DENNIS (CFO) has filed a Form 3 on AKCEA THERAPEUTICS, INC. |
| 04/15/2020 |
4
| Patterson Joshua F. (General Counsel) has filed a Form 4 on AKCEA THERAPEUTICS, INC.|
Txns:
| Granted 12,500 shares
@ $0 |
|
| 04/15/2020 |
4
| PARSHALL B LYNNE (Director) has filed a Form 4 on AKCEA THERAPEUTICS, INC.|
Txns:
| Granted 26,400 options to buy
@ $16.14, valued at
$426.1k
|
|
| 04/15/2020 |
4
| Salzman Amber (Director) has filed a Form 4 on AKCEA THERAPEUTICS, INC.|
Txns:
| Granted 26,400 options to buy
@ $16.14, valued at
$426.1k
|
|
| 04/15/2020 |
4
| SMITH SANDFORD D (Director) has filed a Form 4 on AKCEA THERAPEUTICS, INC.|
Txns:
| Granted 26,400 options to buy
@ $16.14, valued at
$426.1k
|
|
| 04/15/2020 |
4
| YANG MICHAEL J. (Director) has filed a Form 4 on AKCEA THERAPEUTICS, INC.|
Txns:
| Granted 26,400 options to buy
@ $16.14, valued at
$426.1k
|
|
| 04/15/2020 |
4
| Yanni Barbara (Director) has filed a Form 4 on AKCEA THERAPEUTICS, INC.|
Txns:
| Granted 26,400 options to buy
@ $16.14, valued at
$426.1k
|
|
| 04/15/2020 |
4
| Hochberg Elaine (Director) has filed a Form 4 on AKCEA THERAPEUTICS, INC.|
Txns:
| Granted 26,400 options to buy
@ $16.14, valued at
$426.1k
|
|
| 04/15/2020 |
4
| KLEIN JOSEPH III (Director) has filed a Form 4 on AKCEA THERAPEUTICS, INC.|
Txns:
| Granted 26,400 options to buy
@ $16.14, valued at
$426.1k
|
|
| 03/31/2020 |
4/A
| McDevitt Damien (CEO) has filed a Form 4 on AKCEA THERAPEUTICS, INC.|
Txns:
| Granted 60,000 shares
@ $0
Granted 120,000 options to buy
@ $12.76, valued at
$1.5M
|
|
| 03/25/2020 |
4
| Patterson Joshua F. (General Counsel) has filed a Form 4 on AKCEA THERAPEUTICS, INC.|
Txns:
| Sold 335 shares
@ $11.7555, valued at
$3.9k
|
|
| 03/25/2020 |
4
| Jenne Kyle (Chief Commercial Officer) has filed a Form 4 on AKCEA THERAPEUTICS, INC.|
Txns:
| Sold 779 shares
@ $11.7503, valued at
$9.2k
|
|
|